S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
The gold catalyst we’ve waited for (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The gold catalyst we’ve waited for (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
The gold catalyst we’ve waited for (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
The gold catalyst we’ve waited for (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The gold catalyst we’ve waited for (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
The gold catalyst we’ve waited for (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
The gold catalyst we’ve waited for (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The gold catalyst we’ve waited for (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
The gold catalyst we’ve waited for (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
The gold catalyst we’ve waited for (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The gold catalyst we’ve waited for (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
The gold catalyst we’ve waited for (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
NASDAQ:APLT

Applied Therapeutics - APLT Earnings Date, Estimates & Call Transcripts

$0.84
0.00 (0.00%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.82
▼
$0.86
50-Day Range
$0.84
▼
$1.21
52-Week Range
$0.50
▼
$2.73
Volume
38,713 shs
Average Volume
303,505 shs
Market Capitalization
$40.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.13
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

APLT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

APLT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

APLT Earnings Date and Information

Applied Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 11th, 2023 based off prior year's report dates.

Applied Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/11/2023
(Estimated)		        
11/9/2022Q3 2022($0.45)($0.40)+$0.05($0.40)
8/12/2022Q2 2022($0.80)($0.80)($0.64)
5/12/2022Q1 2022($0.82)($0.88)($0.06)($0.88)    
3/10/2022Q4 2021($1.22)($1.04)+$0.18($1.04)
11/12/20219/30/2021($1.15)($1.09)+$0.06($1.09)
8/11/20216/30/2021($1.13)($0.99)+$0.14($0.99)
5/10/20213/31/2021($1.01)($1.00)+$0.01($1.00)
3/17/202112/31/2020($1.25)($1.06)+$0.19($1.06)
11/17/20209/30/2020($1.02)($1.33)($0.31)($1.33)  
8/11/20206/30/2020($0.69)($1.27)($0.58)($1.27)
5/11/20203/31/2020($0.82)($0.59)+$0.23($0.59)
3/13/2020Q4 2019($0.63)($1.57)($0.94)($1.57)
11/13/2019Q3($0.4940)($0.63)($0.1360)($0.63)
8/12/2019Q2 2019($0.4770)($0.60)($0.1230)($0.60)
6/21/2019Q1 2019($0.39)($1.58)($1.19)($1.58)












Applied Therapeutics Earnings - Frequently Asked Questions

When is Applied Therapeutics's earnings date?

Applied Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 11th, 2023 based off last year's report dates. Learn more on APLT's earnings history.

How much profit does Applied Therapeutics generate each year?

Applied Therapeutics (NASDAQ:APLT) has a recorded net income of -$105.58 million. APLT has generated -$2.40 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:APLT) was last updated on 3/28/2023 by MarketBeat.com Staff